54232-43-8Relevant articles and documents
HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
-
, (2018/01/11)
The invention relates to a novel heterocyclic compound inhibiting a cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same as an effective ingredient. The heterocyclic compound according to the present invention or pharmaceutically acceptable salt thereof can be effectively used in treating or preventing cancers, degenerative brain diseases, etc.
DI-MACROCYCLES
-
, (2014/06/11)
The invention relates to chemical compounds and complexes that can be used in therapeutic and diagnostic applications.
PYRIDIN- 2 -AMIDES USEFUL AS CB2 AGONISTS
-
Page/Page column 138, (2013/02/27)
The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.